Latest Insider Transactions at Timber Pharmaceuticals, Inc. (TMBR)
This section provides a real-time view of insider transactions for Timber Pharmaceuticals, Inc. (TMBR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Timber Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Timber Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2023
|
Alan Mendelsohn EVP & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
35,193
+49.86%
|
-
|
|
Aug 20
2023
|
John Koconis CEO & Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
70,385
+49.86%
|
-
|
|
Aug 20
2023
|
Joseph Lucchese EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
35,193
+50.0%
|
-
|
|
Apr 15
2023
|
Lubor Gaal Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+40.2%
|
-
|
|
Apr 15
2023
|
Gianluca Pirozzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+40.2%
|
-
|
|
Apr 15
2023
|
David E Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+40.2%
|
-
|
|
Apr 15
2023
|
Edward J Sitar Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,327
+32.38%
|
-
|
|
Dec 15
2022
|
Edward J Sitar Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+30.12%
|
$2,500
$1.63 P/Share
|
|
Apr 15
2022
|
Lubor Gaal Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 15
2022
|
Gianluca Pirozzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 15
2022
|
Edward J Sitar Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+47.62%
|
-
|
|
Apr 15
2022
|
David E Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Mar 04
2022
|
Zachary Rome Director |
SELL
Payment of exercise price or tax liability
|
Direct |
19,630
-24.75%
|
$0
$0.28 P/Share
|
|
Mar 04
2022
|
Zachary Rome Director |
BUY
Exercise of conversion of derivative security
|
Direct |
79,326
+50.0%
|
$0
$0.01 P/Share
|
|
Dec 15
2021
|
John Koconis CEO & Chairman |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$0
$0.38 P/Share
|
|
Nov 23
2021
|
Edward J Sitar Director |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$0
$0.46 P/Share
|
|
Nov 23
2021
|
Alan Mendelsohn EVP & CMO |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$0
$0.47 P/Share
|
|
Sep 02
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
225,000
-6.03%
|
$0
$0.94 P/Share
|
|
Sep 01
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,500
-3.87%
|
$0
$0.92 P/Share
|
|
Aug 31
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-3.72%
|
$0
$0.91 P/Share
|
|
Aug 30
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-2.42%
|
$0
$0.93 P/Share
|
|
Aug 26
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-2.36%
|
$0
$0.92 P/Share
|
|
Aug 25
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-2.31%
|
$0
$0.91 P/Share
|
|
Aug 24
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-2.26%
|
$0
$0.93 P/Share
|
|
Aug 20
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-1.12%
|
$0
$0.91 P/Share
|
|
Aug 19
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-1.1%
|
$0
$0.95 P/Share
|
|
Aug 18
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
75,000
-1.63%
|
$75,000
$1.0 P/Share
|
|
Jun 15
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
28,450
-0.61%
|
$28,450
$1.26 P/Share
|
|
Jun 14
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
146,465
-3.06%
|
$146,465
$1.27 P/Share
|
|
Jun 10
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
185,229
-3.73%
|
$185,229
$1.26 P/Share
|
|
Jun 09
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
96,481
-1.9%
|
$96,481
$1.27 P/Share
|
|
Jun 08
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
305,540
-5.69%
|
$305,540
$1.29 P/Share
|
|
Jun 02
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,879
-0.18%
|
$9,879
$1.26 P/Share
|
|
Jun 01
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,670
-0.16%
|
$8,670
$1.26 P/Share
|
|
May 28
2021
|
Tardi Med Sciences LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
47,736
-0.88%
|
$47,736
$1.27 P/Share
|
|
Mar 03
2021
|
Alan Mendelsohn EVP & CMO |
BUY
Open market or private purchase
|
Indirect |
1,988
+50.0%
|
$3,976
$2.17 P/Share
|